from Reuters: Health News https://reut.rs/2IExt1R
Tuesday, 23 April 2019
AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval
AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.
from Reuters: Health News https://reut.rs/2IExt1R
from Reuters: Health News https://reut.rs/2IExt1R
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment